Growth Metrics

Galectin Therapeutics (GALT) EBIT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 32.96%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -50.81%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.47%
7 Evaxion A 64.16 Bn 64.14 Bn - 16.35%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 55.96%
10 Galectin Therapeutics 165.77 Mn 151.67 Mn - 26.68%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 26.68%
Dec 31, 2025 31.85%
Sep 30, 2025 19.75%
Jun 30, 2025 21.77%
Mar 31, 2025 7.37%
Dec 31, 2024 -18.73%
Sep 30, 2024 -3.22%
Jun 30, 2024 -11.28%
Mar 31, 2024 -15.16%
Dec 31, 2023 -6.88%
Sep 30, 2023 -15.65%
Jun 30, 2023 -13.84%
Mar 31, 2023 -42.37%
Dec 31, 2022 -27.02%
Sep 30, 2022 -41.56%
Jun 30, 2022 -47.35%
Mar 31, 2022 -61.31%
Dec 31, 2021 -35.49%
Sep 30, 2021 -45.43%
Jun 30, 2021 -29.66%
Mar 31, 2021 -14.78%
Dec 31, 2020 -48.89%
Sep 30, 2020 -10.32%
Jun 30, 2020 -10.57%
Mar 31, 2020 10.18%
Dec 31, 2019 -4.10%
Sep 30, 2019 14.23%
Jun 30, 2019 18.27%
Mar 31, 2019 29.70%
Dec 31, 2018 13.94%
Sep 30, 2018 23.12%
Jun 30, 2018 6.89%
Mar 31, 2018 4.78%
Dec 31, 2017 14.02%
Sep 30, 2017 -8.28%
Jun 30, 2017 -10.18%
Mar 31, 2017 -0.70%
Dec 31, 2016 -17.93%
Sep 30, 2016 -8.57%
Jun 30, 2016 -29.50%
Mar 31, 2016 -28.55%
Dec 31, 2015 -25.27%
Sep 30, 2015 -26.76%
Jun 30, 2015 -20.40%
Mar 31, 2015 -35.33%
Dec 31, 2014 -3.46%
Sep 30, 2014 -19.59%
Jun 30, 2014 -4.11%
Mar 31, 2014 -34.00%
Dec 31, 2013 -29.57%
Sep 30, 2013 -43.01%
Jun 30, 2013 -23.57%